NCT04096638 Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04093115 Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma Status WITHDRAWN Phase PHASE2
NCT04074967 Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04060342 GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma Status TERMINATED Phase PHASE1
NCT04045496 A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04003025 Body Composition and Prognosis in Head and Neck Squamous Cell Carcinoma (HNSCC) Status WITHDRAWN Phase N/A
NCT04001543 Efficacy of an Oral Immunomodulatory Nutrient on Survival During Postoperative Concomitant Chemoradiotherapy in Head and Neck Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT04000529 Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies Status TERMINATED Phase PHASE1
NCT03998696 An Experimental Study to Compare Treatment Response and Toxicities of Concurrent Chemoradiation With Weekly Cisplatin and Three Weekly Cisplatin in Locally Advanced Head and Neck Cancer. Status COMPLETED Phase PHASE4
NCT03993353 Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT03983954 Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03953976 INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy Status COMPLETED Phase PHASE2
NCT03953443 Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC Status COMPLETED Phase N/A
NCT03916627 Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03896412 Detection of Circulating Tumor DNA in p16- Locally Advanced Head Neck Squamous Cell Carcinoma Status COMPLETED Phase NA